According to Inogen's latest financial reports the company has $0.12 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.12 B | -31.3% |
2022-12-31 | $0.18 B | -23.83% |
2021-12-31 | $0.24 B | 6.18% |
2020-12-31 | $0.23 B | 10.58% |
2019-12-31 | $0.20 B | -13% |
2018-12-31 | $0.24 B | 38.18% |
2017-12-31 | $0.17 B | 52.74% |
2016-12-31 | $0.11 B | 37.38% |
2015-12-31 | $82.89 M | 45.86% |
2014-12-31 | $56.83 M | 320.35% |
2013-12-31 | $13.52 M | -10.53% |
2012-12-31 | $15.11 M | 286.89% |
2011-12-31 | $3.9 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ResMed RMD | $0.21 B | 63.65% | ๐บ๐ธ USA |
Masimo MASI | $0.16 B | 26.88% | ๐บ๐ธ USA |
Chart Industries GTLS | $0.18 B | 46.57% | ๐บ๐ธ USA |
Allied Healthcare Products AHPI | $3.31 M | -97.42% | ๐บ๐ธ USA |
Philips PHG | $2.06 B | 1,510.99% | ๐ณ๐ฑ Netherlands |